Routine postoperative imaging is important after urMugiya S, Nagata M, Suzuki T, Sugiyama TAUA 2011 Annual Meeting 2011.05.17 Washington, D.2011.05.14-*一般演題(口演)
Experimental study on the pathogenesis of chronic uMugiya S, Nagata M, Ozono S AUA 2011 Annual Meeting 2011.05.16 Washington, D.2011.05.14-*一般演題(口演)
Mugiya S, Nagata M, Kurita Y, Ozono S : Ureteroscopic evaluation and treatment of chronic unilateral hematuria : Analysis of the latest 20 cases. 2010 AUA Annual Meeting, May, 2010,San Francisco,USA.
Takayama T, Sugiyama T, Kai F, Ito T, Furuse H, Mugiya S, Ozono S.: Ipsilateral solitary adrenal involvement in renal cell carcinoma should be staged as M1 The 27th Japan-korea Urological Congress, September, 2010,Kyoto,Japan.
Mugiya S, Nagata M, Takayama T, Furuse H, Ozono S : Retrograde endoscopic laser therapy for urothelial carcinoma of the renal pelvis using flexible uretero-reno videoscope with Narrow Band Imaging (NBI). The 27th Japan-korea Urological Congress, September, 2010,Kyoto,Japan.
Kai F, Kendig RD, Frazier DP, Taneja P, Maglic D, Sugiyama T, Fry EA, Willingham MC, Inoue K .: Arf-independent activation of p53 by the Dmp1 tumor suppressor. 101th American Association for Cancer Research (AACR), April, 2010,Washington,D.C.
Matsumoto R, Otsuka A, Mugiya S, Ozono S.: Expression and distribution of alpha1-adenoceptor subtypes in human urothelium, suburothelium and detrusor muscle of the urinary bladder. ICS-IUGA 2010, August, 2010,Toronto,Canada.
Takayama T, Kai F, Sugiyama T, Furuse H, Mugiya S, Ozono S.: Efficacy of Adjuvant Interferon-alpha Therapy Following Curative Resection in Renal Cell Carcinoma Before the Molecular Targeting Therapy Era-.第9回アジア臨床腫瘍学会(ACOS), August, 2010, Gifu, Japan.
Ozono S, Ueda T, Hoshi S, Yamaguchi A, Maeda H, Fukuyama Y, Ohashi Y, Tsukamoto T, Naito S, Akaza H, Degarelix Japan Study Grop.:The efficacy and safety of degarelix, a GnRH receptor antagonist:A multicenter, randomized, maintenance dose-finding phase Ⅱ study with Japanese prostate cancer patients.2011 Genitourinary Cancers Symposium, February,2011, Orlando, Florida USA.
大園誠一郎:わが国の進行腎癌治療の展望-NCCN-GL Asia Consensus Statement kidney Cancer 2009と腎癌診療GL改訂版の作成にあたって-. Nagoya RCC Forum, 2010年4月,名古屋市.
Mugiya S,Nagata M, Imanishi T,Kurita Y,Ozono S.: Ureteroscopic evaluation and Treatment of chronic unilateral hematuria: Anaylysis of the latest 20 cases. The 26th Korea-Japan urological congress,September 18, 2009,Seoul,Korea.
Mugiya S,Ozono S,Nagata M,Takayama T,Kurita Y.: Investigation of preoperative serum c-reactive protein level on the prognosis for patients with localized renal cell carcinoma.American Urological Association, 2009 Annual Meeting, April 27, 2009, Chicago, Illinois USA.''''
Takayama T, Zaima N, Kyono Y,Miyazaki M,Takaoka T,Nagata M, Kai F,Sugiyama T, Setou M,Ozono S.: Analysis of lipid profile of renal cell carcinoma by imaging mass spectrometry. 欧州癌・臨床腫瘍学会(Joint ECCO 15 34th ESMO), September 21, 2009, Berlin,Germany.''''
Otsuka A,Matsumoto R, Shinbo H, Imanishi T,Kurita Y,Ozono S.: Distribution of β-adrenoceptor subtypes in suburothelial interstitial cells of the human urinary bladder.International Continence Society 39th Annual Meeting, October 3, 2009, San Francisco, USA.''''
Nagata M,Takayama T,Mugiya S,Ozono S.:The relationship between metabolism of the glyoxylate and the species. 6th Eurolithiasis Society (eULIS) Symposium - 14th European Symposium on Urolithiasis,October 17, 2009,Como,Italy.
Mizumori O, Zembutsu H, Kato Y, Tsukamoto T, Fujioka T, Tomita Y, Kitamura T,Ozono S, Miki T, Naito S, Akaza H, Nakamura Y.: Predicting response to IL-2 and IFN-α combination therapy for renal cell carcinoma through genome-wide gene expression profiling. AACR/JCA Joint Conference: Cancer Genomics, Epigenomics, and the Development of Novel Therapeutics,February 6, 2010,Waikoloa,Hawaii.
Mugiya S, Fujimoto H, Uemura H, Shinohara N, Takahashi M, Tomita Y, Niwakawa M, Yuasa T, Naito S, Akaza H.:Phase II study of sunitinib in Japanese patients (pts) with metastatic renal cell carcinoma (mRCC):overall survival (OS) and updated results.ASCO GU, March 6, 2010, San Francisco, USA.''''
Takaoka N, Takayama T, Miyazaki M, Nagata M, Ozono S.:MODIFICATION OF PRIMERS FOR GRHPR GENOTYPING- AVOIDING ALLELE DROPOUT BY SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) AND HOMOLOGY SEQUENCE."11th International Symposium on Urolithiasis", September 2008, Nice,France.
Mugiya S, Nagata M, Imanishi T, Kurita Y, %Ushiyama T,Ozono S%.: Novel observation in upper urinary tract by digital flexible video ureterorenoscope with Narrow Band Imaging(NBI)."25th Japan-Korea UROLOGICAL CONGRESS", September 2008,Okayama,JAPAN.
Mugiya S, Ozono S, Nagata M, Takayama T, Ushiyama T.: INVESTIGATION OF PREOPERATIVE SERUM C-REACTIVE PROTEIN ELEVATION IN RECURRENCE FOR PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA."2008 AUA Annual Meeting", May 2008, Orlando, USA.
Suzuki K, Fujisawa M, Matsumoto T, Takeda M, Usui T, Matsuda T,Ozono S, Kumon H, Ichikawa T, Miki T.:Alternative non-steroidal antiandrogen therapy for advanced prostate cancer that has relapsed after initial maximum androgen blockade. "44th Annual Meeting of the American Society of Clinical Oncology", May 2008, Chicago, Illinois.
Takayama T, Takaoka N, Miyazaki M, Nagata M, Mugiya S, Johnin K, Okada Y, Kuhara T, Cramer SD,Ozono S.: The relationship between molecular analysis and ethnic differences of genotype in Japanese patients with primary hyperoxaluria type 2."11th International Symposium on Urolithiasis", September 2008, Nice, France.
Hinotsu S, Naito S,Ozono S, Sumiyoshi Y, Noguchi S, Terai A, Tsukamoto T, Hirao Y, Akaza H.: Prophylactic effect of 1.5-year maintenance PMCJ-9 (BCG Connaught strain) therapy for non-muscle invasive urothelial carcinoma of the bladder (NMIBC): Results of interim analysis of prospective randomized phase Ⅲ trial in Japan."2009 Genitourinary Cancers Symposium: A Multidisciplinary Approach", February 2009, Orlando, Florida USA.
Takayama T, Teratani T,Takaoka N, Sugiyama T, Kai F, Nozawa R,Ozono S.: Detection of the transcript for brain-type fatty acid binding protein in the tumor and urine of patients with renal cell carcinoma."2009 Genitourinary Cancers Symposium: A Multidisciplinary Approach", February 2009, Orlando, Florida USA.
Mugiya S, Ozono S, Kai F,Nagata M, Takayama T, Ushiyama T.: INVESTIGATION OF PREOPERATIVE SERUM C-REACTIVE PROTEIN LEVEL ON THE PROGNOSIS FOR PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA. "The 24th Korea-Japan Urological Congress", October 2007,Cheongju,Korea.
Suzuki K, Maruyama S, Takeda M,Otsuka A, Ozono S, Ehlert FJ,Yamada S.: Quantification of pharmacologically relevant muscarinic receptor subtypes in human detrusor muscle, mucosa and parotid gland by irreversible inactivation of M3 receptors by 4-DAMP mustard. "5th International Symposium on Receptor Mechanisms,Signal Transduction and Drug Effects(第5回国際受容体シンポジウム)", May 2007, Shizuoka, JAPAN.
Otsuka A, Shinbo H, Maruyama S, Yamada S,Ozono S.: A molecular biological and functional analysis of β-adrenoceptors in human detrusor smooth muscle and urothelium. "5th International Symposium on Receptor Mechanisms,Signal Transduction and Drug Effects(第5回国際受容体シンポジウム)", May 2007, Shizuoka, JAPAN.
Terada H,Harada M, Ozono S.: LOH in Hemodialysis Patients. "The Second Japan-ASEAN Men's Health & Aging Conference", November 2007,Ishikawa,JAPAN.
大園誠一郎:The Paradigm shift in treatment of advanced RCC in Japan,The 17th Bayer Symposium Advance in Urology:泌尿器科腫瘍に対する分子標的アプローチ-基礎と臨床の最新知見-、2007.08.04、東京都
Mugiya S, Ozono S, Nagata M, Takayama T: URETEROSCOPIC EVALUATION AND LASER TREATMENT OF CHRONIC UNILATERAL HEMATURIA. "24th World Congress on Endourology & SWL", August 2006,Cleveland,USA.
Mugiya S, Nagata M, Furuse H, Hirano Y,Ushiyama T, %Ozono S: Investigation of factors affecting recurrence in patients with superficial bladder cancer treated with intravesical BCG therapy after TURBT. "The 23rd Japan-Korea urological congress", September 2006,Nara,JAPAN.
Otsuka A, Shinbo H, Hasebe K, Isogaya M,Ushiyama T, Ozono S: Effects of beta3-agonist, AJ-9677, on mediating relaxation of the rat, monkey and human urinary bladder in vitro. "International Continence Society 36th Annual Meeting", November 2006,Christchurch,New Zealand.